Cargando…
Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration
INTRODUCTION: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications of pregnancy. Previous studies by our group have...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443218/ https://www.ncbi.nlm.nih.gov/pubmed/30988643 http://dx.doi.org/10.2147/IJWH.S188303 |
_version_ | 1783407826063851520 |
---|---|
author | Drobnjak, Tijana Jónsdóttir, Anna Margrét Helgadóttir, Helga Runólfsdóttir, Margrét Soffía Meiri, Hamutal Sammar, Marei Osol, George Mandalà, Maurizio Huppertz, Berthold Gizurarson, Sveinbjörn |
author_facet | Drobnjak, Tijana Jónsdóttir, Anna Margrét Helgadóttir, Helga Runólfsdóttir, Margrét Soffía Meiri, Hamutal Sammar, Marei Osol, George Mandalà, Maurizio Huppertz, Berthold Gizurarson, Sveinbjörn |
author_sort | Drobnjak, Tijana |
collection | PubMed |
description | INTRODUCTION: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications of pregnancy. Previous studies by our group have shown that PP13 lowers blood pressure in pregnant rats, increases the size and weight of pups and placentas, and induces vasodilation of resistance arteries through endothelial signaling pathways involving endothelial nitric oxid synthase and prostaglandin. METHODS: In the present study, the effect of PP13 was investigated in nonpregnant female Sprague Dawley rats (n=27). Osmotic pumps were surgically implanted subcutaneously that released a constant dose of PP13 or saline over 7 days. Most animals were sacrificed 6 days after the end of PP13 release (on day 13), while some were sacrificed immediately at the end of day 7 (the last PP13 release day), to compare the short- and long-term impact of PP13 on vessels’ growth and size. RESULTS: The uterine vessels were significantly expanded in the group exposed to recombinant PP13 (rPP13) compared to the control (saline) group. Both veins and arteries were significantly expanded by rPP13 with a more pronounced effect after 13 days compared to the corresponding vessels after 7 days. Furthermore, the long-term effect of treatment by rPP13 was more pronounced in the veins compared to the corresponding arteries. The effect of a PP13 variant with a histidine-tag (His-PP13) remained the same between 7 and 13 days. CONCLUSION: In conclusion, PP13 might play a key role in the expansive remodeling of the uterine vessels, reflecting what would happen if the rat was pregnant, preparing the uterine vascu-lature for the increase in uteroplacental blood flow, which is necessary for normal pregnancy. We suggest that PP13 could act by NO signaling pathways, a hypothesis that requires future study. |
format | Online Article Text |
id | pubmed-6443218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64432182019-04-15 Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration Drobnjak, Tijana Jónsdóttir, Anna Margrét Helgadóttir, Helga Runólfsdóttir, Margrét Soffía Meiri, Hamutal Sammar, Marei Osol, George Mandalà, Maurizio Huppertz, Berthold Gizurarson, Sveinbjörn Int J Womens Health Original Research INTRODUCTION: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications of pregnancy. Previous studies by our group have shown that PP13 lowers blood pressure in pregnant rats, increases the size and weight of pups and placentas, and induces vasodilation of resistance arteries through endothelial signaling pathways involving endothelial nitric oxid synthase and prostaglandin. METHODS: In the present study, the effect of PP13 was investigated in nonpregnant female Sprague Dawley rats (n=27). Osmotic pumps were surgically implanted subcutaneously that released a constant dose of PP13 or saline over 7 days. Most animals were sacrificed 6 days after the end of PP13 release (on day 13), while some were sacrificed immediately at the end of day 7 (the last PP13 release day), to compare the short- and long-term impact of PP13 on vessels’ growth and size. RESULTS: The uterine vessels were significantly expanded in the group exposed to recombinant PP13 (rPP13) compared to the control (saline) group. Both veins and arteries were significantly expanded by rPP13 with a more pronounced effect after 13 days compared to the corresponding vessels after 7 days. Furthermore, the long-term effect of treatment by rPP13 was more pronounced in the veins compared to the corresponding arteries. The effect of a PP13 variant with a histidine-tag (His-PP13) remained the same between 7 and 13 days. CONCLUSION: In conclusion, PP13 might play a key role in the expansive remodeling of the uterine vessels, reflecting what would happen if the rat was pregnant, preparing the uterine vascu-lature for the increase in uteroplacental blood flow, which is necessary for normal pregnancy. We suggest that PP13 could act by NO signaling pathways, a hypothesis that requires future study. Dove Medical Press 2019-03-27 /pmc/articles/PMC6443218/ /pubmed/30988643 http://dx.doi.org/10.2147/IJWH.S188303 Text en © 2019 Drobnjak et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Drobnjak, Tijana Jónsdóttir, Anna Margrét Helgadóttir, Helga Runólfsdóttir, Margrét Soffía Meiri, Hamutal Sammar, Marei Osol, George Mandalà, Maurizio Huppertz, Berthold Gizurarson, Sveinbjörn Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title_full | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title_fullStr | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title_full_unstemmed | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title_short | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
title_sort | placental protein 13 (pp13) stimulates rat uterine vessels after slow subcutaneous administration |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443218/ https://www.ncbi.nlm.nih.gov/pubmed/30988643 http://dx.doi.org/10.2147/IJWH.S188303 |
work_keys_str_mv | AT drobnjaktijana placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT jonsdottirannamargret placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT helgadottirhelga placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT runolfsdottirmargretsoffia placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT meirihamutal placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT sammarmarei placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT osolgeorge placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT mandalamaurizio placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT huppertzberthold placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration AT gizurarsonsveinbjorn placentalprotein13pp13stimulatesratuterinevesselsafterslowsubcutaneousadministration |